Scott Curley is a global biopharma executive with over 20 years of leadership experience in commercial operations across North America, Asia, and Europe. Currently serving as Head of Commercial Operations at Gilead Sciences, Scott has held several significant roles in prominent companies such as Amarin Corporation, AstraZeneca, and GlaxoSmithKline. In their previous position as General Manager for the UK and Ireland at Amarin, Scott demonstrated strategic leadership. Scott has also contributed to the industry as a Board Member for The Hong Kong Association of the Pharmaceutical Industry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices